Costa Rica will debate marijuana and medical marijuana bills
Costa Rican lawmakers will restart the debate bill (Expediente N.° 21.388) Legalize marijuana and medical marijuana. The bill was approved by the Environmental Committee of the Legislative Assembly in November last year, but its submission to the plenary session of the Parliament was delayed.
The author of the bill is the independent legislator Zoila Rosa love it, one agronomist And lawyers, who has Waving Economic and health arguments supporting legalization. In addition to ensuring that Costa Ricans have access to cannabis treatment, the development of the cannabis industry is seen as a potential driver for growth and increasing government revenue.
According to the proposed law, cannabis is defined as cannabis with a THC content of less than 1%. The bill distinguishes between therapeutic (Therapeutic use) And medical (Medical use) product.This is interesting because the terms Cure cannabis with Medicinal cannabis Sometimes they can be used interchangeably. However, according to the definition of the Act, therapeutic use does not require medical supervision or authorization, and medical use does require medical supervision. Despite this distinction, these terms are used in tandem throughout the Act, with the exception of Article 13.2, which only provides for the licensed manual production of products for therapeutic use.
In addition to the requirements for general agricultural activities, the Act does not establish any licensing requirements for hemp cultivation. As for medical marijuana, growers must obtain permission from the Ministry of Agriculture and Livestock. For their part, those seeking to produce finished products need to obtain permission from the Ministry of Health. The bill does not involve the permission of foreign parties. Given the discussions surrounding the proposed law and the overall openness of the Costa Rican economy, this omission may indicate the intention of allowing foreign participation in the emerging cannabis industry.
According to the provisions of the Act, the qualification of a medical marijuana patient is determined by the person’s doctor. Patients will be authorized to grow their own cannabis.
The new law will impose a 1% tax on medical marijuana (but not marijuana) transactions. If the bill becomes law, the executive branch will have six months to issue regulations.
Overall, the bill seems to strike a good balance between the government’s desire to obtain budgetary gains from the legalization of marijuana and to provide the industry with room for growth as it sees fit. The reduced regulatory burden on cannabis and smart adjustments are commendable.
Given Costa Rica’s success in attracting investment from foreign companies, especially electronics and medical equipment manufacturers, there are reasons to be hopeful about the prospects of its cannabis industry-assuming the legislative assembly votes!